HURA logo

HURA TuHURA Biosciences, Inc.

NASDAQ Capital Market · Biotechnology · Healthcare

$1.25
-0.11 (-8.09%)

TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies designed to effectively combat the mechanisms by which cancers develop resistance to existing immunotherapy treatments. Its operations are based in Tampa, Florida.

Market Cap: $82.20Mwww.tuhurabio.com

Price

No data yet.

Social Signal Score

47
5d
—
30d
50
3 mentions
—
60d
50
4 mentions
—
90d
42
5 mentions
—
news: 5

Analyst Ratings

3 analysts
Buyconsensus
Strong Buy 0Buy 3Hold 0Sell 0Strong Sell 0

Revenue

$0.00
$0.00
Dec 2016Sep 2026

Analyst Estimates

FY2025
$-0.62
$-0.64–$-0.60
2 analysts
FY2026
$-0.49
$-0.56–$-0.45
3 analysts
FY2027
$-0.50
$-0.63–$-0.39
3 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
James A. Bianco
Sector
Healthcare
Industry
Biotechnology
Employees
22
Beta
-0.01
Country
US
Piotroski score
2 / 9 (Weak)
Altman Z-score
-6.10
www.tuhurabio.com